Tabula Rasa HealthCare (NASDAQ:TRHC) had its target price increased by Oppenheimer from $35.00 to $47.00 in a research report sent to investors on Tuesday morning. They currently have an outperform rating on the stock.

Other analysts have also recently issued research reports about the company. BidaskClub cut Tabula Rasa HealthCare from a strong-buy rating to a buy rating in a research report on Wednesday, December 6th. Citigroup began coverage on Tabula Rasa HealthCare in a research report on Thursday, January 4th. They issued a buy rating for the company. Zacks Investment Research cut Tabula Rasa HealthCare from a buy rating to a hold rating in a research report on Wednesday, March 7th. William Blair reissued an outperform rating on shares of Tabula Rasa HealthCare in a research report on Tuesday. Finally, Piper Jaffray Companies boosted their price objective on Tabula Rasa HealthCare to $43.00 and gave the stock an overweight rating in a research report on Tuesday. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of Buy and an average target price of $33.50.

How to Become a New Pot Stock Millionaire

Tabula Rasa HealthCare (NASDAQ TRHC) opened at $35.12 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.66. Tabula Rasa HealthCare has a 52 week low of $11.59 and a 52 week high of $39.81. The company has a market capitalization of $696.90 and a PE ratio of -206.59.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its earnings results on Monday, March 12th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). Tabula Rasa HealthCare had a negative net margin of 2.27% and a negative return on equity of 5.58%. The firm had revenue of $43.93 million during the quarter, compared to analysts’ expectations of $38.91 million. During the same quarter last year, the firm earned $0.10 EPS. The business’s revenue for the quarter was up 60.9% compared to the same quarter last year. equities research analysts forecast that Tabula Rasa HealthCare will post 0.03 EPS for the current fiscal year.

In related news, CFO Brian W. Adams acquired 5,391 shares of the stock in a transaction dated Friday, January 12th. The shares were bought at an average cost of $14.23 per share, for a total transaction of $76,713.93. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Bruce Luehrs sold 15,664 shares of the company’s stock in a transaction that occurred on Friday, March 9th. The shares were sold at an average price of $37.09, for a total value of $580,977.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 295,021 shares of company stock valued at $10,167,309. Insiders own 45.80% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in TRHC. Strs Ohio bought a new stake in Tabula Rasa HealthCare during the 4th quarter worth approximately $137,000. MetLife Investment Advisors LLC acquired a new position in Tabula Rasa HealthCare during the 4th quarter worth $139,000. New York State Common Retirement Fund lifted its holdings in Tabula Rasa HealthCare by 257.0% during the 2nd quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after buying an additional 7,199 shares in the last quarter. BlueCrest Capital Management Ltd acquired a new position in Tabula Rasa HealthCare during the 4th quarter worth $237,000. Finally, Teachers Advisors LLC lifted its holdings in Tabula Rasa HealthCare by 203.5% during the 2nd quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock worth $248,000 after buying an additional 11,063 shares in the last quarter. Institutional investors own 53.03% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Tabula Rasa HealthCare (TRHC) Price Target Raised to $47.00” was posted by Daily Political and is the property of of Daily Political. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.dailypolitical.com/2018/03/14/tabula-rasa-healthcare-trhc-price-target-raised-to-47-00.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.